| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel.
|
Ann Intern Med
|
2012
|
7.04
|
|
2
|
Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy.
|
Epilepsia
|
2010
|
5.64
|
|
3
|
Overestimates of survival after HAART: implications for global scale-up efforts.
|
PLoS One
|
2008
|
4.20
|
|
4
|
Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211.
|
J Infect Dis
|
2007
|
3.75
|
|
5
|
The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time.
|
J Acquir Immune Defic Syndr
|
2009
|
3.67
|
|
6
|
HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.
|
Clin Infect Dis
|
2007
|
3.05
|
|
7
|
A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV.
|
J Clin Epidemiol
|
2004
|
2.97
|
|
8
|
Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy.
|
PLoS Med
|
2008
|
2.82
|
|
9
|
Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials.
|
Clin Infect Dis
|
2014
|
2.65
|
|
10
|
Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy.
|
AIDS
|
2006
|
2.57
|
|
11
|
A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia.
|
J Acquir Immune Defic Syndr
|
2005
|
2.15
|
|
12
|
The influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study.
|
Arch Intern Med
|
2007
|
1.79
|
|
13
|
Racial disparities in hypertension control, but not treatment intensification.
|
Am J Hypertens
|
2009
|
1.59
|
|
14
|
HIV treatment adherence, drug resistance, virologic failure: evolving concepts.
|
Infect Disord Drug Targets
|
2011
|
1.53
|
|
15
|
Use of pharmacy refill data as a measure of antiretroviral adherence.
|
Curr HIV/AIDS Rep
|
2007
|
1.53
|
|
16
|
Out-of-pocket costs of HAART limit HIV treatment responses in Botswana's private sector.
|
AIDS
|
2006
|
1.51
|
|
17
|
Patterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North America.
|
AIDS
|
2012
|
1.42
|
|
18
|
Randomized, controlled trial of therapy interruption in chronic HIV-1 infection.
|
PLoS Med
|
2004
|
1.41
|
|
19
|
Antiretroviral failure despite high levels of adherence: discordant adherence-response relationship in Botswana.
|
J Acquir Immune Defic Syndr
|
2008
|
1.36
|
|
20
|
Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention.
|
Clin Infect Dis
|
2010
|
1.36
|
|
21
|
Adherence to warfarin assessed by electronic pill caps, clinician assessment, and patient reports: results from the IN-RANGE study.
|
J Gen Intern Med
|
2007
|
1.35
|
|
22
|
Pain, mood, and substance abuse in HIV: implications for clinic visit utilization, antiretroviral therapy adherence, and virologic failure.
|
J Acquir Immune Defic Syndr
|
2012
|
1.27
|
|
23
|
HIV/AIDS-specific quality of life and adherence to antiretroviral therapy over time.
|
J Acquir Immune Defic Syndr
|
2007
|
1.26
|
|
24
|
Pain and physical and psychological symptoms in ambulatory HIV patients in the current treatment era.
|
J Pain Symptom Manage
|
2011
|
1.23
|
|
25
|
Medication beliefs as mediators of the health literacy-antiretroviral adherence relationship in HIV-infected individuals.
|
AIDS Behav
|
2007
|
1.22
|
|
26
|
Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients.
|
J Acquir Immune Defic Syndr
|
2007
|
1.17
|
|
27
|
Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study.
|
Ann Intern Med
|
2011
|
1.17
|
|
28
|
Risk factors for nonadherence to warfarin: results from the IN-RANGE study.
|
Pharmacoepidemiol Drug Saf
|
2008
|
1.15
|
|
29
|
Monitoring of long-term toxicities of HIV treatments: an international perspective.
|
AIDS
|
2003
|
1.14
|
|
30
|
MACH14: a multi-site collaboration on ART adherence among 14 institutions.
|
AIDS Behav
|
2013
|
1.14
|
|
31
|
Association between efavirenz-based compared with nevirapine-based antiretroviral regimens and virological failure in HIV-infected children.
|
JAMA
|
2013
|
1.09
|
|
32
|
Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial.
|
Clin Infect Dis
|
2010
|
1.07
|
|
33
|
Adherence to hepatitis C virus therapy and early virologic outcomes.
|
Clin Infect Dis
|
2009
|
1.06
|
|
34
|
Endothelial cell density to predict endothelial graft failure after penetrating keratoplasty.
|
Arch Ophthalmol
|
2010
|
1.05
|
|
35
|
Slow efavirenz metabolism genotype is common in Botswana.
|
J Acquir Immune Defic Syndr
|
2008
|
1.04
|
|
36
|
Three-year safety and efficacy of vicriviroc, a CCR5 antagonist, in HIV-1-infected treatment-experienced patients.
|
J Acquir Immune Defic Syndr
|
2010
|
1.04
|
|
37
|
Heterogeneity among studies in rates of decline of antiretroviral therapy adherence over time: results from the multisite adherence collaboration on HIV 14 study.
|
J Acquir Immune Defic Syndr
|
2013
|
1.03
|
|
38
|
Lack of association between retrospectively collected pharmacy refill data and electronic drug monitoring of antiretroviral adherence.
|
AIDS Behav
|
2008
|
1.01
|
|
39
|
Membrane-based, sedimentation-assisted plasma separator for point-of-care applications.
|
Anal Chem
|
2013
|
1.01
|
|
40
|
Early immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiretroviral therapy with active tuberculosis.
|
J Infect Dis
|
2013
|
1.00
|
|
41
|
Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors.
|
BMC Cancer
|
2013
|
0.96
|
|
42
|
Provider guidance for linking patients to antiretroviral therapy adherence interventions: recommendations from an IAPAC advisory committee on adherence monitoring and support.
|
J Int Assoc Provid AIDS Care
|
2013
|
0.96
|
|
43
|
The validity of self-reported medication adherence as an outcome in clinical trials of adherence-promotion interventions: Findings from the MACH14 study.
|
AIDS Behav
|
2014
|
0.95
|
|
44
|
Risk factors for medication non-adherence in an HIV infected population in the Dominican Republic.
|
AIDS Behav
|
2011
|
0.94
|
|
45
|
Early mortality and AIDS progression despite high initial antiretroviral therapy adherence and virologic suppression in Botswana.
|
PLoS One
|
2011
|
0.94
|
|
46
|
Outcomes of HIV-infected patients receiving care at multiple clinics.
|
AIDS Behav
|
2014
|
0.93
|
|
47
|
Can we predict daily adherence to warfarin?: Results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study.
|
Chest
|
2009
|
0.93
|
|
48
|
HIV-1-specific CD4+ T cell responses in chronically HIV-1 infected blippers on antiretroviral therapy in relation to viral replication following treatment interruption.
|
J Clin Immunol
|
2006
|
0.92
|
|
49
|
Patient attitudinal and behavioral factors associated with warfarin non-adherence at outpatient anticoagulation clinics.
|
Int J Behav Med
|
2010
|
0.90
|
|
50
|
Epidemiologic studies of adverse effects of anti-retroviral drugs: how well is statistical power reported.
|
Pharmacoepidemiol Drug Saf
|
2005
|
0.89
|
|
51
|
Rapid psychosocial function screening test identified treatment failure in HIV+ African youth.
|
AIDS Care
|
2012
|
0.89
|
|
52
|
A randomized trial of a nursing intervention for HIV disease management among persons with serious mental illness.
|
Psychiatr Serv
|
2011
|
0.88
|
|
53
|
Is antiretroviral therapy adherence substantially worse on weekends than weekdays?
|
J Acquir Immune Defic Syndr
|
2010
|
0.88
|
|
54
|
Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression.
|
J Infect Dis
|
2003
|
0.87
|
|
55
|
Incidence and risk factors for weight loss during dual HIV/hepatitis C virus therapy.
|
J Acquir Immune Defic Syndr
|
2007
|
0.87
|
|
56
|
Association between HIV replication and serum leptin levels: an observational study of a cohort of HIV-1-infected South African women.
|
J Int AIDS Soc
|
2010
|
0.87
|
|
57
|
Effect of GB virus C viremia on HIV acquisition and HIV set-point.
|
AIDS
|
2005
|
0.87
|
|
58
|
The odds that clinically unrecognized poor or partial adherence confuses population pharmacokinetic/pharmacodynamic analyses.
|
Basic Clin Pharmacol Toxicol
|
2005
|
0.87
|
|
59
|
Risk factors for suboptimal antiretroviral therapy adherence in HIV-infected adolescents in Gaborone, Botswana: a pilot cross-sectional study.
|
Patient Prefer Adherence
|
2013
|
0.87
|
|
60
|
Vitamin D status in HIV-infected patients with and without tuberculosis: a pilot study.
|
J Acquir Immune Defic Syndr
|
2012
|
0.86
|
|
61
|
How long is the right interval for assessing antiretroviral pharmacy refill adherence?
|
J Acquir Immune Defic Syndr
|
2010
|
0.84
|
|
62
|
Validation of the Pediatric Symptom Checklist in HIV-infected Batswana.
|
J Child Adolesc Ment Health
|
2011
|
0.84
|
|
63
|
Mapping patient-identified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen's Behavioral Model.
|
AIDS Care
|
2015
|
0.84
|
|
64
|
Proceedings of the Second Annual Deep Brain Stimulation Think Tank: What's in the Pipeline.
|
Int J Neurosci
|
2015
|
0.82
|
|
65
|
Super Learner Analysis of Electronic Adherence Data Improves Viral Prediction and May Provide Strategies for Selective HIV RNA Monitoring.
|
J Acquir Immune Defic Syndr
|
2015
|
0.82
|
|
66
|
Self-reported hepatitis B and C virus infections had low sensitivity among HIV-infected patients.
|
J Clin Epidemiol
|
2006
|
0.81
|
|
67
|
Acceptance of hepatitis B vaccination by pregnant adolescents.
|
MCN Am J Matern Child Nurs
|
2005
|
0.81
|
|
68
|
Evaluating the President's Emergency Plan for AIDS Relief: time to scale it up.
|
Ann Intern Med
|
2009
|
0.81
|
|
69
|
The association between poor antiretroviral adherence and unsafe sex: differences by gender and sexual orientation and implications for scale-up of treatment as prevention.
|
AIDS Behav
|
2014
|
0.81
|
|
70
|
A sensitive and selective liquid chromatography/tandem mass spectrometry method for quantitative analysis of efavirenz in human plasma.
|
PLoS One
|
2013
|
0.81
|
|
71
|
Application of high-frequency Granger causality to analysis of epileptic seizures and surgical decision making.
|
Epilepsia
|
2014
|
0.81
|
|
72
|
Adherence to hepatitis C virus therapy in HIV/hepatitis C-coinfected patients.
|
AIDS Behav
|
2013
|
0.80
|
|
73
|
Incidence of transaminitis among HIV-infected patients with occult hepatitis B.
|
J Clin Virol
|
2008
|
0.80
|
|
74
|
Antiretroviral therapy interruptions result in loss of protective humoral immunity to neoantigens in HIV-infected individuals.
|
AIDS
|
2012
|
0.79
|
|
75
|
Natural history of patients with low-level HIV viremia on antiretroviral therapy.
|
AIDS Patient Care STDS
|
2004
|
0.78
|
|
76
|
Sickle cell patient with an acute chest syndrome and a negative chest X-ray: potential role of the ventilation and perfusion (V/Q) lung scan.
|
Am J Hematol
|
2003
|
0.77
|
|
77
|
Randomized trial of time-limited interruptions of protease inhibitor-based antiretroviral therapy (ART) vs. continuous therapy for HIV-1 infection.
|
PLoS One
|
2011
|
0.77
|
|
78
|
Factors associated with a willingness to accept rapid HIV testing in an urban emergency department.
|
AIDS Behav
|
2014
|
0.77
|
|
79
|
Untreated hypertension and the emergency department: a chance to intervene?
|
Acad Emerg Med
|
2008
|
0.76
|
|
80
|
Baseline predictors of efavirenz-containing antiretroviral regimen adverse experiences.
|
Pharmacoepidemiol Drug Saf
|
2014
|
0.76
|
|
81
|
Health Outcomes of HIV-Infected People with Mental Illness.
|
AIDS Behav
|
2015
|
0.75
|
|
82
|
Research letter: Do physicians discuss political issues with their patients?
|
J Gen Intern Med
|
2006
|
0.75
|
|
83
|
Toward improved adverse event/suspected adverse drug reaction reporting.
|
Pharmacoepidemiol Drug Saf
|
2003
|
0.75
|
|
84
|
CYP2B6 516G>T Minor Allele Protective of Late Virologic Failure in Efavirenz-treated HIV-Infected Patients in Botswana.
|
J Acquir Immune Defic Syndr
|
2017
|
0.75
|